$19.64
2.72% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US6373722023
Symbol
NRC

National Research Corporation Stock price

$19.64
+1.68 9.35% 1M
-10.70 35.27% 6M
-19.92 50.35% YTD
-21.86 52.67% 1Y
-22.54 53.43% 3Y
-42.78 68.53% 5Y
+7.25 58.50% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.52 2.72%
ISIN
US6373722023
Symbol
NRC
Sector

Key metrics

Market capitalization $461.07m
Enterprise Value $511.24m
P/E (TTM) P/E ratio 17.48
EV/FCF (TTM) EV/FCF 20.30
EV/Sales (TTM) EV/Sales 3.55
P/S ratio (TTM) P/S ratio 3.20
P/B ratio (TTM) P/B ratio 13.32
Dividend yield 2.44%
Last dividend (FY24) $0.48
Revenue growth (TTM) Revenue growth -3.07%
Revenue (TTM) Revenue $144.15m
EBIT (operating result TTM) EBIT $37.46m
Free Cash Flow (TTM) Free Cash Flow $25.18m
Cash position $3.46m
EPS (TTM) EPS $1.12
Short interest 2.96%
Show more

Is National Research Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

National Research Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a National Research Corporation forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a National Research Corporation forecast:

Hold
100%

Financial data from National Research Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
144 144
3% 3%
100%
- Direct Costs 62 62
0% 0%
43%
82 82
6% 6%
57%
- Selling and Administrative Expenses 38 38
4% 4%
27%
- Research and Development Expense - -
-
-
43 43
7% 7%
30%
- Depreciation and Amortization 5.94 5.94
2% 2%
4%
EBIT (Operating Income) EBIT 37 37
8% 8%
26%
Net Profit 27 27
6% 6%
19%

In millions USD.

Don't miss a Thing! We will send you all news about National Research Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

National Research Corporation Stock News

Neutral
Business Wire
6 days ago
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareInnovation--Signature Healthcare has selected NRC Health to enhance its network through human-centered healthcare solutions and data-driven insights.
Neutral
Business Wire
about one month ago
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $35.8 million compared with approximately $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24 compared with $0.32 for the 2023 quarter. At ...
Neutral
Business Wire
4 months ago
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2024 and several other corporate developments. Financial Results Revenue for the quarter was approximately $35 million compared with approximately $36 million in the 2023 quarter. Earnings per diluted share were $0.26 compared with $0.29 for the 2023 quarter...

Company Profile

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

Head office United States
CEO Michael Hays
Employees 435
Founded 1981
Website www.nrchealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today